company background image
GTMS

Greenbrook TMSTSX:GTMS Stock Report

Market Cap

CA$155.8m

7D

-2.2%

1Y

22.4%

Updated

22 Oct, 2021

Data

Company Financials +
GTMS fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

GTMS Overview

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States.

Price History & Performance

Summary of all time highs, changes and price drops for Greenbrook TMS
Historical stock prices
Current Share PriceCA$8.75
52 Week HighCA$6.65
52 Week LowCA$22.40
Beta1.11
1 Month Change-7.90%
3 Month Change-41.20%
1 Year Change22.38%
3 Year Change-41.47%
5 Year Changen/a
Change since IPO-43.00%

Recent News & Updates

Sep 17
Is Greenbrook TMS (TSE:GTMS) Using Too Much Debt?

Is Greenbrook TMS (TSE:GTMS) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Shareholder Returns

GTMSCA HealthcareCA Market
7D-2.2%1.1%1.4%
1Y22.4%3.7%33.2%

Return vs Industry: GTMS exceeded the Canadian Healthcare industry which returned 3.7% over the past year.

Return vs Market: GTMS underperformed the Canadian Market which returned 33.2% over the past year.

Price Volatility

Is GTMS's price volatile compared to industry and market?
GTMS volatility
GTMS Beta1.11
Industry Beta1.23
Market Beta1

Stable Share Price: GTMS is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: GTMS's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011394Bill Leonardhttps://www.greenbrooktms.com

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy for the treatment of depression and related psychiatric services. The company operates approximately 128 treatment centers.

Greenbrook TMS Fundamentals Summary

How do Greenbrook TMS's earnings and revenue compare to its market cap?
GTMS fundamental statistics
Market CapUS$125.97m
Earnings (TTM)-US$30.43m
Revenue (TTM)US$46.94m

2.7x

P/S Ratio

-4.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
GTMS income statement (TTM)
RevenueUS$46.94m
Cost of RevenueUS$34.91m
Gross ProfitUS$12.03m
ExpensesUS$42.46m
Earnings-US$30.43m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-1.71
Gross Margin25.62%
Net Profit Margin-64.83%
Debt/Equity Ratio112.7%

How did GTMS perform over the long term?

See historical performance and comparison

Valuation

Is Greenbrook TMS undervalued compared to its fair value and its price relative to the market?

8.03x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate GTMS's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate GTMS's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: GTMS is unprofitable, so we can't compare its PE Ratio to the Canadian Healthcare industry average.

PE vs Market: GTMS is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate GTMS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: GTMS is overvalued based on its PB Ratio (8x) compared to the CA Healthcare industry average (3.1x).


Future Growth

How is Greenbrook TMS forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

38.3%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if GTMS's forecast earnings growth is above the savings rate (1.6%).

Earnings vs Market: Insufficient data to determine if GTMS's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: GTMS's revenue (38.3% per year) is forecast to grow faster than the Canadian market (6.8% per year).

High Growth Revenue: GTMS's revenue (38.3% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if GTMS's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Greenbrook TMS performed over the past 5 years?

-59.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GTMS is currently unprofitable.

Growing Profit Margin: GTMS is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: GTMS is unprofitable, and losses have increased over the past 5 years at a rate of 59.3% per year.

Accelerating Growth: Unable to compare GTMS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: GTMS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (56.6%).


Return on Equity

High ROE: GTMS has a negative Return on Equity (-212.13%), as it is currently unprofitable.


Financial Health

How is Greenbrook TMS's financial position?


Financial Position Analysis

Short Term Liabilities: GTMS's short term assets ($32.2M) exceed its short term liabilities ($17.9M).

Long Term Liabilities: GTMS's short term assets ($32.2M) do not cover its long term liabilities ($37.1M).


Debt to Equity History and Analysis

Debt Level: GTMS's debt to equity ratio (112.7%) is considered high.

Reducing Debt: GTMS had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: GTMS has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: GTMS has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 27.9% each year.


Dividend

What is Greenbrook TMS current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate GTMS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate GTMS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if GTMS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if GTMS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of GTMS's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.7yrs

Average management tenure


CEO

Bill Leonard (56 yo)

10.75yrs

Tenure

US$705,000

Compensation

Mr. William P. Leonard, also knonw as Bill, has been the President and Chief Executive Officer of Greenbrook TMS Inc. since 2011 and serves as its Director since February 2018. Mr. Leonard is the President...


CEO Compensation Analysis

Compensation vs Market: Bill's total compensation ($USD705.00K) is above average for companies of similar size in the Canadian market ($USD164.70K).

Compensation vs Earnings: Bill's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: GTMS's management team is considered experienced (3.7 years average tenure).


Board Members

Experienced Board: GTMS's board of directors are considered experienced (3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31.8%.


Top Shareholders

Company Information

Greenbrook TMS Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Greenbrook TMS Inc.
  • Ticker: GTMS
  • Exchange: TSX
  • Founded: 2011
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$155.766m
  • Shares outstanding: 17.80m
  • Website: https://www.greenbrooktms.com

Number of Employees


Location

  • Greenbrook TMS Inc.
  • 890 Yonge Street
  • 7th Floor
  • Toronto
  • Ontario
  • M4W 3P4
  • Canada

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/22 23:10
End of Day Share Price2021/10/22 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.